A randomized placebo-controlled trial of the efficacy and safety of pregabalin in the treatment of subjects with neuropathic pain associated with lumbo-sacral radiculopathy
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 19 May 2010 Result published in Pain.
- 09 Oct 2008 Actual patient number (276) added as reported by ClinicalTrials.gov
- 29 Nov 2007 Status changed from recruiting to completed.